-
digital.ahrq.gov/sites/default/files/docs/page/SureScripts%20Final%20Report.pdf
January 11, 2007 - including monitoring the use of controlled
substances and managing chronic conditions such as diabetes, asthma
-
hcup-us.ahrq.gov/datainnovations/clinicaldata/AHRQFINALREPORTVHI.jsp
July 01, 2016 - alike.
112 — The risk-adjusted rate (per 100,000 population) of discharges for adult asthma
-
www.ahrq.gov/sites/default/files/wysiwyg/ncepcr/tools/PCMH/pcpf-module-27-ehr-and-pcmh.pdf
January 15, 2025 - health
outcomes of specified groups such as patients with diabetes, elderly patients, or patients with
asthma
-
www.ahrq.gov/sites/default/files/wysiwyg/cahps/news-and-events/events/20150917/introducing_the_new_cahps_c&g_survey3.0.pdf
September 01, 2015 - emergency department visit, hospital stay, or a chronic health
condition, such as uncontrolled diabetes or asthma
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/preventive/chipra-204-fullreport.pdf
January 01, 2014 - the age range for an existing adult-
focused measure, or it may fill a gap in measurement (e.g., for asthma
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-134-fullreport.pdf
November 01, 2019 - the age range for an existing adult-
focused measure, or it may fill a gap in measurement (e.g., for asthma
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-233-fullreport.pdf
August 07, 2018 - the age range for an existing adult-
focused measure, or it may fill a gap in measurement (e.g., for asthma
-
cdsic.ahrq.gov/sites/default/files/2024-09/Quartz%20Assessment%20Report_Public%20Version_0.pdf
January 01, 2024 - A Systematic Review of the Effectiveness of Text Message
Reminders on Asthma Medication Adherence.
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/obesity-in-children-and-adolescents-screening
June 18, 2024 - depression, medical events or conditions that may be associated with high BMI [eg, cardiovascular events, asthma
-
www.ahrq.gov/sites/default/files/wysiwyg/ncepcr/resources/primer-for-pbrn-business-opportunities.pdf
September 01, 2015 - Implementing asthma guidelines using practice facilitation
and local learning collaboratives: a randomized
-
digital.ahrq.gov/sites/default/files/docs/page/findings-and-lessons-from-the-improving-quality-through-clinician-use-of-health-it.pdf
January 28, 2014 - base to identify instances
of likely medication non-adherence for six chronic
conditions (persistent asthma
-
digital.ahrq.gov/sites/default/files/docs/publication/r21hs018811-krist-final-report-2012.pdf
January 01, 2012 - vaccination coverage
among persons aged > or =65 years and persons aged
18-64 years with diabetes or asthma
-
ce.effectivehealthcare.ahrq.gov/diagnostic-safety/resources/issue-briefs/dxsafety-current-state-references.html
January 01, 2024 - Design of the Reducing Diagnostic Error to Improve Patient Safety (REDEfINE) in COPD and asthma study
-
effectivehealthcare.ahrq.gov/products/cancer-end-of-life-quality-meaures/research
May 17, 2010 - 287.4, 99.05
DVT
ICD-9: 451, 415.19
DRG: 78
FX
ICD-9: 800-829, 830-839
DRG: 235, 236
Asthma
-
meps.ahrq.gov/data_files/publications/rf50/rf50.pdf
November 01, 2022 - Priority condition
Population Population Population
Percent Percent Percent
(SE) (SE) (SE)
Asthma
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/safety-vaccines-protocol.pdf
January 30, 2020 - For all influenza vaccines,
asthma will be assessed.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/safety-vaccines-protocol.pdf
January 30, 2020 - For all influenza vaccines,
asthma will be assessed.
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1506.pdf
June 01, 2015 - FDA recommends that Afrezza should not be used in patients with chronic lung disease,
such as asthma … bronchospasm.126 FDA advises that Afrezza should not be used in patients with chronic lung
disease, such as asthma
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1506.pdf
June 01, 2015 - FDA recommends that Afrezza should not be used in patients with chronic lung disease,
such as asthma … bronchospasm.126 FDA advises that Afrezza should not be used in patients with chronic lung
disease, such as asthma
-
pcmh.ahrq.gov/page/coordinating-care-medical-neighborhood-critical-components-and-available-mechanisms
June 01, 2011 - Community coalition connects medical practices to community resources, leading to improved asthma and